EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Von Willebrand Factor Antigen, Biomarkers of Inflammation, and Microvascular Flap Thrombosis in Reconstructive Surgery

Rihards Peteris Rocans iD, Janis Zarins iD, Evita Bine iD, Insana Mahauri, Renars Deksnis iD, Margarita Citovica, Simona Donina, Indulis Vanags iD, Sabine Gravelsina iD, Anda Vilmane iD, Santa Rasa-Dzelzkaleja iD, Biruta Mamaja iD

Journal of Clinical Medicine · 12.09.2024 · 13 (18) · 5411

DOI: 10.3390/jcm13185411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.09.2024. Verfasst von Rihards Peteris Rocans und 11 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Clinic, Riga East University Hospital, Hipokrata Street 2, LV-1079 Riga, Latvia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Riga Stradiņš University, European Union’s Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microvascular flap surgery has become a routine option for defect correction. The role of von Willebrand factor antigen (VWF:Ag) in the pathophysiology of flap complications is not fully understood. We aim to investigate the predictive value of VWF:Ag for microvascular flap complications and explore the relationship between chronic inflammation and VWF:Ag.

Methods

This prospective cohort study included 88 adult patients undergoing elective microvascular flap surgery. Preoperative blood draws were collected on the day of surgery before initiation of crystalloids. The plasma concentration of VWF:Ag as well as albumin, neutrophil-to-lymphocyte ratio (NLR), interleukin-6, and fibrinogen were determined.

Results

The overall complication rate was 27.3%, and true flap loss occurred in 11.4%. VWF:Ag levels were higher in true flap loss when compared to patients without complications (217.94 IU/dL [137.27–298.45] vs. 114.14 [95.67–132.71], p = 0.001). Regression analysis revealed the association between VWF:Ag and true flap loss at the cutoff of 163.73 IU/dL (OR 70.22 [10.74–485.28], p = 0.043). Increased VWF:Ag concentrations were linked to increases in plasma fibrinogen (p < 0.001), C-reactive protein (p < 0.001), interleukin-6 (p = 0.032), and NLR (p = 0.019).

Conclusions

Preoperative plasma VWF:Ag concentration is linked to biomarkers of inflammation and may be valuable in predicting complications in microvascular flap surgery.

Schlagwörter

Stichwörter der Autor:innen

flap lossmicrovascular flap complicationsmicrovascular flap thrombosisneutrophil-to-lymphocyte ratioreconstructive surgeryvon Willebrand factor antigen

Autor:innen und Institutionen

  • Intensive Care Clinic, Riga East University Hospital, Hipokrata Street 2, LV-1079 Riga, Latvia.
  • Department of Anaesthesia and Intensive Care, Riga Stradiņš University, Dzirciema Street 16, LV-1007 Riga, Latvia.
  • Department of Hand and Plastic Surgery, Microsurgery Centre of Latvia, Brivibas Street 410, LV-1024 Riga, Latvia.
  • Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia.
  • Surgical Oncology Clinic, Riga East University Hospital, Hipokrata Street 4, LV-1079 Riga, Latvia.
  • Laboratory Department, Riga East University Hospital, Hipokrata Street 2, LV-1079 Riga, Latvia.

ORCID-Profile: Rihards Peteris Rocans, Janis Zarins, Evita Bine, Renars Deksnis, Indulis Vanags, Sabine Gravelsina, Anda Vilmane, Santa Rasa-Dzelzkaleja, Biruta Mamaja

Förderung

  • Riga Stradiņš University
  • European Union’s Horizon 2020 research and innovation program

Zitieren

APA

Rocans, R. P., Zarins, J., Bine, E., Mahauri, I., Deksnis, R., Citovica, M., Donina, S., Vanags, I., Gravelsina, S., Vilmane, A., Rasa-Dzelzkaleja, S., & Mamaja, B. (2024). Von Willebrand Factor Antigen, Biomarkers of Inflammation, and Microvascular Flap Thrombosis in Reconstructive Surgery. Journal of Clinical Medicine, 13(18), 5411. https://doi.org/10.3390/jcm13185411

Vancouver

Rocans RP, Zarins J, Bine E, Mahauri I, Deksnis R, Citovica M, et al. Von Willebrand Factor Antigen, Biomarkers of Inflammation, and Microvascular Flap Thrombosis in Reconstructive Surgery. Journal of Clinical Medicine. 2024;13(18):5411. doi:10.3390/jcm13185411

BibTeX
@article{Rocans2024,
  author = {Rocans, Rihards Peteris and Zarins, Janis and Bine, Evita and Mahauri, Insana and Deksnis, Renars and Citovica, Margarita and Donina, Simona and Vanags, Indulis and Gravelsina, Sabine and Vilmane, Anda and Rasa-Dzelzkaleja, Santa and Mamaja, Biruta},
  title = {Von Willebrand Factor Antigen, Biomarkers of Inflammation, and Microvascular Flap Thrombosis in Reconstructive Surgery},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {18},
  pages = {5411},
  doi = {10.3390/jcm13185411}
}
Kostenlos starten →